Procept Biorobotics

Yahoo Finance • 11 days ago

PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch

With a street-high upside potential of 109.4%, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the 10 best robotics stocks to buy under $30.PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and... Full story

Yahoo Finance • 13 days ago

Procept projects $390M-$410M 2026 revenue as Hydros pricing guides $450K-$460K for rest of year

Earnings Call Insights: PROCEPT BioRobotics (PRCT) Q1 2026 MANAGEMENT VIEW * "Over the past 6 months, we have taken decisive actions to reset the organization. We have sharpened our focus on operational excellence, accountability and c... Full story

Yahoo Finance • 18 days ago

Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock

What happened According to a filing with the Securities and Exchange Commission dated April 23, 2026, Chicago Capital, LLC increased its holding in PROCEPT BioRobotics Corporation(NASDAQ:PRCT) by 969,592 shares from the previous quarter.... Full story

Yahoo Finance • 2 months ago

Procept BioRobotics price target lowered to $30 from $47 at Truist

Truist lowered the firm’s price target on Procept BioRobotics (PRCT) to $30 from $47 but keeps a Buy rating on the shares. The company’s Q4 missed estimates, though its Analyst Day laid out a case for sustainable growth of 25% or more thro... Full story

Yahoo Finance • 2 months ago

A Look At PROCEPT BioRobotics (PRCT) Valuation After Q4 Revenue Miss And Softer 2026 Outlook

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. PROCEPT BioRobotics (PRCT) is back in focus after its Q4 2025 revenue miss, softer 2026 outlook, and sharp share price reac... Full story

Yahoo Finance • 2 months ago

Stocks Pressured as Chipmakers Tumble

The S&P 500 Index ($SPX) (SPY) today is down -0.74%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.13%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.40%.  March E-mini S&P futures (ESH26) are down -0.74%, and March E-mini Na... Full story

Yahoo Finance • 2 months ago

Stocks Mostly Lower as Nvidia Earnings Fail to Impress

The S&P 500 Index ($SPX) (SPY) today is down -0.35%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.75%.  March E-mini S&P futures (ESH26) are down -0.40%, and March E-mini Na... Full story

Yahoo Finance • 2 months ago

PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth

Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased organizational discipline Strong revenue outlook, procedure growth, expanding margins, and path to pr... Full story

Yahoo Finance • 3 months ago

PROCEPT BioRobotics Corporation (PRCT): A Bull Case Theory

We came across a bullish thesis on PROCEPT BioRobotics Corporation on Notes From The Beauty Contest’s Substack by Crashkolnikov. In this article, we will summarize the bulls’ thesis on PRCT. PROCEPT BioRobotics Corporation's share was trad... Full story

Yahoo Finance • 3 months ago

PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day

PROCEPT BioRobotics SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions i... Full story

Yahoo Finance • 3 months ago

Wall Street Has a Positive Opinion on ​PROCEPT BioRobotics (PRCT), Here’s Why

​PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the Overlooked Small Cap Stocks to Buy Now. Wall Street is positive on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ahead of its fiscal Q4 2025 earnings, expected to be released on... Full story

Yahoo Finance • 5 months ago

Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT)

Procept Biorobotics Corp. (NASDAQ:PRCT) is one of the most promising mid-cap healthcare stocks under $50. On December 12, UBS analyst Danielle Antalffy initiated coverage with a bullish rating on Procept Biorobotics Corp. (NASDAQ:PRCT). S... Full story

Yahoo Finance • 6 months ago

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that... Full story

Yahoo Finance • 6 months ago

Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT)

​PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the Fast-Growing Small Cap Stocks to Buy According to Analysts. On November 10, Matthew O’Brien from Piper Sandler reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:... Full story

Yahoo Finance • 6 months ago

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today r... Full story

Yahoo Finance • 6 months ago

2 Robotics Stocks Riding the Sensor and Medical Boom

Key Points Robotics companies building enabling systems like sensors and LiDAR attracted $1.6 billion in 2025, as every robot needs vision capabilities. Medical robotics shows the clearest path from startup to profitability, with surgical... Full story

Yahoo Finance • 7 months ago

Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?

Key Points Chicago Capital added 999,873 shares of Procept BioRobotics with an estimated purchase value of $45.65 million based on the average price for the quarter. The transaction represents a trade size equal to 1.12% of Chicago Capita... Full story

Yahoo Finance • 7 months ago

PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025

SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today a... Full story

Yahoo Finance • 9 months ago

PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the top robotics to buy according to analysts. On August 7, Wells Fargo maintained its Overweight rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) but reduced its price targe... Full story

Yahoo Finance • 9 months ago

Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best medical device stocks to buy according to analysts. On August 8, Leerink Partners analyst Mike Kratky reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT)... Full story